New study aims to replace dangerous diabetes drugs with safer alternatives

NCT ID NCT05933174

Recruiting now Disease control Sponsor: Ian J. Neeland, MD Source: ClinicalTrials.gov ↗

First seen Nov 16, 2025 · Last updated May 21, 2026 · Updated 29 times

Summary

This study helps older adults with type 2 diabetes move away from sulfonylureas—older pills that can cause dangerous low blood sugar, falls, and heart problems—and switch to newer, safer medications. About 220 participants will be given simple questions to ask their doctor, while doctors receive extra training. The goal is to start more conversations and get patients onto better treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE2DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University Hospitals Cleveland Medical Center
RECRUITING

Cleveland, Ohio, 44106, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

TYPE2DIABETES TYPE2DIABETES